Scope is a family-run company for three generations with a heritage of bringing evidence-based, premium products to healthcare professionals and end-consumers alike. Scope offers innovative Ocular Surface Disease Diagnostic & Management Dry Eye and Blepharitis products. Scope operates in both the United Kingdom and Ireland and ensures its product offerings are well-established with a track record of successfully treating patients worldwide.
Ophthalmics Portfolio: Hylo Range®, Blephex, ComplEye (Eye drop dispenser), OPTASE® Moist Heat Mask, OPTASE® Tea Tree Oil Lid Wipes, Omega Eye, VitA-POS®, Ketofall and Prokera®.
Heidelberg Engineering continuously optimizes imaging and healthcare IT technologies to provide ophthalmic diagnostic solutions that empower clinicians to improve patient care. From its inception in 1990, the company has collaborated with scientists, clinicians and industry to develop innovative products that deliver clinically relevant benefits.
Uncompromising quality and education play a large part in fostering the diagnostic confidence that has become synonymous with the global brand. The company’s substantial expertise in the development and implementation of intelligent image and data management solutions complements its distinguished history in the design, manufacture and distribution of ophthalmic diagnostic instruments. Heidelberg Engineering’s growing product portfolio combines these core technologies: confocal microscopy, scanning lasers and optics, optical coherence tomography (OCT), real-time image processing and analytics, multimodal image management solutions (PACS), electronic medical records (EMR) and data mining.
Spectrum has been servicing the UK ophthalmic market for over 30 years. During this time Spectrum has introduced many revolutionary innovations. In 1987 Spectrum launched the OMS phaco and vitrectomy systems.
With the advent of injectable intra-ocular lenses (IOL) in the late 1980’s, Spectrum brought to the UK market the first foldable IOL which could be implanted following cataract surgery via a 3.2mm incision. Spectrum were also first to the UK market with an injectable IOL, from Hoya and have been bringing new developments to the market since.
Spectrum has grown to become the largest independent supplier of ophthalmic surgical and diagnostic products in the UK market.
Established in the UK in 2008, Thea Pharmaceuticals is built around 3 central pillars which form the foundation of our spirit and success: innovation, education and professionalism.
Our growth and success follows a series of exciting product launches and acquisitions meaning we now offer over 30 products across a wide range of key therapy areas serving the complex needs of eye health professionals.
Medicom Healthcare is a fast growing company in the Global Ophthalmic Market. We have a reputation of success: we have developed, manufactured, and commercialised Pharmaceutical and Medical Device products in the therapeutic classes of: Dry Eye, Ocular Hygiene, Infection, Blepharitis, Allergy and Glaucoma.
In the UK, Chiesi Ltd. employs just over 400 dedicated employees, who are based out of our head office in Manchester, the Research and Development centre in Chippenham, and across the UK as part of our experienced field-based sales teams. As with every part of the Chiesi group, we embrace a shared set of values and a common code of ethical conduct. This demands the highest standards of reliability, transparency, and individual accountability, in everything we do. It emphasises the importance of collaborative working, putting people first and exchanging knowledge. Implicit in all of these values is a responsible attitude to the social and environmental impact of our actions, in this regard, Chiesi was proud to achieve the B Corp certification in June 2019.
We work on important therapy areas, such as organ transplantation and rare diseases, alongside our treatments for respiratory conditions, Chiesi Ltd. is poised to extend further still the contribution we make to public health in the UK. As the winners of an independent Top Employer Award in the UK and Europe for the seventh consecutive year, ours is a culture where innovation and professional excellence flourish.
VISUfarma is pan-European ophthalmic specialty pharmaceutical company with a clear mission; to bring global innovation to European eye health. We are an ambitious and fast growing ophthalmology player, commercialising a wide portfolio of products and devices across Europe. Our promise is to offer high quality products and to spread eye health innovation and knowledge, from across the globe, throughout Europe.
We have a range of innovative eye health products with a special focus on dry eye, retinal diseases and glaucoma.
medac Pharma is a privately owned, pharmaceutical company specialising in the development, diagnosis and treatment of diseases within the key areas of oncology, urology and autoimmune.
The company was originally founded in Germany in 1970 and the UK operation was established in 1993. Since then we have become known for developing innovative products from standard cancer chemotherapy to niche speciality medicines.
medac Pharma currently promotes CHEMOSAT®, an innovative system developed to treat liver metastases from uveal melanoma. This works by isolating the liver’s circulatory system, infusing the liver with chemotherapy and then filtering a patient’s blood before returning it to the patient in a procedure called percutaneous hepatic perfusion (PHP).
NuVision Biotherapies Ltd is a spin out company from the University of Nottingham. Our company foundations include the development of a vacuum dried amniotic membrane through a patented “Tereo” process. This aim of our company was to deliver on the recognised benefits of cryopreserved amnion whilst improving the practical and clinical benefits. The ability to store Omnigen at room temperature and its easily manipulated nature enables the delivery of both surgical and in-clinic options whilst the improved biochemistry may directly impact on the clinical effectiveness.
Johnson & Johnson Vision
At Johnson & Johnson Vision, part of Johnson & Johnson Medical Devices Companies, we have a bold ambition: to change the trajectory of eye health around the world.
Through our operating companies, we deliver innovation that enables eye care professionals to create better outcomes for patients throughout their lives, with products and technologies that address unmet needs including refractive error, cataracts and dry eye. In communities with greatest need, we work in collaboration to expand access to quality eye care, and we are committed to helping people see better, connect better and live better.